Daily alternating deferasirox and deferiprone therapy successfully controls iron accumulation in untreatable transfusion-dependent thalassemia patients

MeSH terms

• Adolescent
• Adult
• Blood Transfusion*
• Chelation Therapy / methods*
• Deferasirox / administration & dosage*
• Deferasirox / therapeutic use
• Deferiprone / administration & dosage*
• Deferiprone / therapeutic use
• Drug Administration Schedule
• Drug Synergism
• Female
• Follow-Up Studies
• Humans
• Iron / metabolism*
• Iron Chelating Agents / administration & dosage*
• Iron Chelating Agents / therapeutic use
• Iron Overload / drug therapy*
• Iron Overload / etiology
• Iron Overload / prevention & control
• Male
• Thalassemia / complications
• Thalassemia / therapy*
• Young Adult